tiprankstipranks
Advertisement
Advertisement

STRO Stock Latest News

Sutro Biopharma assumed with a Buy at Truist
The FlySutro Biopharma assumed with a Buy at Truist
5d ago
STRO
Sutro Biopharma Shareholders Back Board, Pay and Auditor
PremiumCompany Announcements
Sutro Biopharma Shareholders Back Board, Pay and Auditor
7d ago
8K
STRO
Analyst Reaffirms Buy on Sutro Biopharma as Advancing ADC Platform and Upcoming STRO-004 Data Drive Upside Optionality
PremiumRatings
Analyst Reaffirms Buy on Sutro Biopharma as Advancing ADC Platform and Upcoming STRO-004 Data Drive Upside Optionality
15d ago
STRO
Sutro Biopharma initiated with an Overweight at Barclays
PremiumThe Fly
Sutro Biopharma initiated with an Overweight at Barclays
19d ago
STRO
Analyst Reiterates Buy on Sutro Biopharma, Maintains $54 Price Target on Differentiated ADC Platform and Pipeline Progress
PremiumRatings
Analyst Reiterates Buy on Sutro Biopharma, Maintains $54 Price Target on Differentiated ADC Platform and Pipeline Progress
21d ago
STRO
Sutro Biopharma price target raised to $10 from $9 at BofA
PremiumThe FlySutro Biopharma price target raised to $10 from $9 at BofA
25d ago
STRO
Sutro Biopharma: Buy Rating on Strong ADC Execution, Cash Runway Into 2028, and Multiple 2026 Catalysts
Premium
Ratings
Sutro Biopharma: Buy Rating on Strong ADC Execution, Cash Runway Into 2028, and Multiple 2026 Catalysts
1M ago
STRO
Wedbush upgrades Sutro Biopharma to Outperform, raises price target to $60
Premium
The Fly
Wedbush upgrades Sutro Biopharma to Outperform, raises price target to $60
1M ago
STRO
Sutro Biopharma upgraded to Outperform from Neutral at Wedbush
PremiumThe Fly
Sutro Biopharma upgraded to Outperform from Neutral at Wedbush
1M ago
STRO
Sutro Biopharma price target raised to $50 from $28 at H.C. Wainwright
PremiumThe Fly
Sutro Biopharma price target raised to $50 from $28 at H.C. Wainwright
1M ago
STRO
Sutro Biopharma price target raised to $43 from $38 at Leerink
PremiumThe Fly
Sutro Biopharma price target raised to $43 from $38 at Leerink
1M ago
STRO
Analyst Reiterates Buy on Sutro Biopharma, Citing STRO-004 Phase I Readout and Broader ADC Platform Potential
PremiumRatings
Analyst Reiterates Buy on Sutro Biopharma, Citing STRO-004 Phase I Readout and Broader ADC Platform Potential
1M ago
STRO
Sutro Biopharma reports Q1 EPS ($2.94), consensus ($3.21)
PremiumThe FlySutro Biopharma reports Q1 EPS ($2.94), consensus ($3.21)
1M ago
STRO
STRO Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
STRO Earnings this Week: How Will it Perform?
1M ago
STRO
Meta downgraded, Qualcomm upgraded: Wall Street’s top analyst calls
Premium
The Fly
Meta downgraded, Qualcomm upgraded: Wall Street’s top analyst calls
2M ago
MG
RS
Sutro Biopharma initiated with an Outperform at Mizuho
PremiumThe Fly
Sutro Biopharma initiated with an Outperform at Mizuho
2M ago
STRO
Sutro Biopharma price target raised to $41 from $35 at Citizens
PremiumThe Fly
Sutro Biopharma price target raised to $41 from $35 at Citizens
2M ago
STRO
Sutro Biopharma presents preclinical data across its pipeline of ADCs
PremiumThe Fly
Sutro Biopharma presents preclinical data across its pipeline of ADCs
2M ago
STRO
Sutro Biopharma price target raised to $35 from $23 at Citizens
PremiumThe Fly
Sutro Biopharma price target raised to $35 from $23 at Citizens
2M ago
STRO
Sutro Biopharma management to meet with Citizens
PremiumThe FlySutro Biopharma management to meet with Citizens
2M ago
STRO
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
Premium
The Fly
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
2M ago
GILD
IMNM
Arm downgraded, Arista Networks upgraded: Wall Street’s top analyst calls
Premium
The Fly
Arm downgraded, Arista Networks upgraded: Wall Street’s top analyst calls
2M ago
ARM
WAL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >